BioAtla is a clinical-stage biotechnology company that researches and develops antibody therapeutics for the treatment of cancer.
Business Model:
Revenue: $29.6M
Employees: 51-200
Address: 11085 Torreyana Road
City: San Diego
State: CA
Zip: 92121
Country: US
BioAtla is a clinical-stage biotechnology company that researches and develops antibody therapeutics for the treatment of cancer.
Contact Phone:
+18585580708
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/15/2020
IPO Valuation:
$578M
Ticker Symbol:
BCAB
IPO Price:
$18/share
Amount Raised:
$189M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2017 | Exuma Biotech | Series A | 0 |
2/2017 | Exuma Biotech | Series A | 0 |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|